The Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) study shows that implanted ventricular assist devices improve survival time and quality of life when used as a permanent therapy in patients who do not qualify for heart transplant. The success of the pulsatile 70 cc stroke volume left ventricular assist device (LVAD) developed by Penn State has led to the development of a 50 cc stroke volume pump for use in patients with smaller chest cavities to benefit a larger patient population. The initial 50 cc pump shows regions of in vivo thrombus formation, which correlate to low wall shear rates within the device. In an in vitro evaluation of three new designs (V-2, V-3, and V-4) of the 50 cc LVAD, identical except for the location and orientation of their outlet ports, particle image velocimetry (PIV) is used to capture planar flow field data within the pumps. V-2 has an outlet port that is located parallel to the inlet. In V-3, the outlet port is rotated away from the inlet port, with the intention of minimizing the amount of fluid turning needed to exit the device. With V-4 the outlet port is moved to the center of the pump to prolong the desirable rotational flow. PIV data were taken at six planar locations within the pump. Although the modifications to the outlet port locations serve their intended purpose, they also introduce unwanted changes in the flow. Poorer wall washing and weaker rotational flow are observed with V-3 and V-4. Although the differences between the devices are subtle, the device that has the most desirable flow characteristics is V-2.
Nearly 5.7 million Americans are afflicted with heart failure, with 670,000 new diagnoses being made each year. 1 In cases of end-stage organ failure, where pharmacologic therapy proves to be ineffective toward heart recovery, heart transplantation is often necessary. The total number of heart transplants performed in 2009 was approximately 2,200, using nearly 97% of available donor hearts for that year. Despite the high rate of transplant success, an estimated 3,100 Americans remain on the waiting list, with nearly 400 patients waitlisted for periods Ͼ5 years. 2 In cases where a lack of transplantation may lead to diminishing heart function or fatality, pulsatile flow (PF) ventricular assist devices (VADs) may be used as a viable form of clinical intervention.
PF VADs have been extensively studied with some through optimization methods, 3 but clinical PF VADS have also been compared with newer generation continuous flow (CF) devices. Significant reductions in pump size with CF VADs allow treatment for patients with smaller chest cavities, although their lack of pulsatility is a deviation from physiologic cardiovascular flow. Although the impact of pulsatility in VADs is a continuing topic, studies have shown greater left ventricular (LV) volume unloading and LV remodeling in PF compared with CF devices, suggesting greater myocardial rest toward cardiac recovery. 4 -7 Additionally, improvements in renal circulation have been shown to occur with PF support, 8, 9 as well as improved peripheral vascular reactivity, 10 when compared with CF VADs. Penn State is developing a 50 cc PF pump, driven by a reciprocating pusher plate and based on a previous 70 cc device, LionHeart, to benefit a larger patient population.
Perhaps, the most significant technical problem to overcome in the development of the 50 cc PF device is thrombogenicity. In vivo studies have shown blood sac thrombi forming on the flexible blood sac and between the outflow cannula and the vasculature. 11 These complications may lead to thromboembolic damage to vital organs and remain a critical design challenge for VADs before clinical use. It has been demonstrated that these areas of thrombus formation are largely influenced by the local fluid dynamics within the Penn State 50 cc device. Fluid flow and shear rates within the original 50 cc device, V-0, were first studied by Hochareon et al. 12 using high-speed videography and particle image velocimetry (PIV). Regions of low wall shear, persisting throughout the cardiac cycle, were correlated to regions of thrombus formation seen in V-0 animal studies. 11, 13 Oley et al. 14 further investigated the flow in V-0 with changes in off-design performance conditions characteristic of animal studies. Low (60 bpm), medium (75 bpm), and high (90 bpm) beat rates at a 35% systolic duration and a systolic duration of 50% at the medium beat rate were studied with PIV while holding the cardiac output constant. Results showed that both increased heart rate and increased systolic duration produced favorable flow characteristics, as they caused the pump to fill faster and produced increased velocities within the device. These higher velocities correlate with improved wall washing and perhaps reduced thrombus formation, although areas of thrombosis were still present in V-0 animal explants.
These regions of in vivo clot deposition were addressed with four additional iterations of the 50 cc VAD, shown alongside V-0 in Figure 1 . The second generation device (V-1), no longer directly scaled from the 70 cc device, has a more rounded front wall and a more tapered connection between the ports and the blood sac. The ports in the V-1 device are also located closer to the front of the model. Kreider et al. 15 found that the newer design did a poorer job of establishing the desired flow patterns within the device, and the larger chamber depth was less conducive to confining the inlet jet and establishing good wall washing. To further understand VAD performance and improve on V-1, 50 cc device iterations V-2, V-3, and V-4 were constructed and are studied here. All three VADs are geometrically identical except for the location and orientation of their outlet ports. These modifications were compared with respect to thrombus potential by characterizing flow patterns within the pump body and inlet and outlet ports through two-dimensional PIV. Resulting flow fields were studied for improved rotational flow and wall washing in pursuing VAD selection for clinical testing.
Materials and Methods
The main design alterations to V-1, applicable to pumps V-2, V-3, and V-4, are elongated inlet and outlet ports that have been moved further from the pusher plate to reduce the stress on the blood sac. The transitions between the ports and the pump body are curved to minimize potential blood damage and thrombus formation. The front walls of the pumps are flat, as illustrated in Figure 1 , to promote the desired wall washing effects previously seen in V-0.
The location of the outlet ports, for the designs, is shown in Figure 2 . V-2 has the ports located in the same location as V-1, with the outlet parallel to the inlet. In V-3, the outlet port has been rotated away from the inlet port and placed lower in the model. This was done to provide a smoother exit path for the rotational flow from the device. With V-4, the outlet port has been moved to the center of the pump to minimize the distance between ports and, hopefully, to improve wall washing in the region between ports.
To accomplish PIV measurements within the PF VADs, all pumps were constructed out of transparent acrylic with an index of refraction of 1.49. The front half of the pumps are identical in geometry to the implanted polyurethane blood sac and the rear half of the models are composed of a flexible diaphragm made of the sac material. Directionality of the flow was maintained by using Bjork-Shiley Monostrut mechanical heart valves. The valves consist of pyrolytic carbon occluders, with 23 mm and 21 mm valves seated in Teflon casings and fixed within the mitral and aortic ports, respectively. The optimal inlet valve angle is 30°toward the front and outer wall of the inlet port, as this orientation has been shown to produce higher velocities in thrombus-prone regions and increase the duration of wall washing in V-0, compared with other valve angles. 15 Because of the similarity of the inlet ports, we expect that these flow patterns will be similar in the new devices. A 0°orientation was used for the outlet valve. Both valve angles are illustrated in Figure 3 .
The device is driven by a Superpump positive displacement pusher plate pump (StarFish Medical, Victoria, BC). The pusher plate, constructed out of Teflon, did not attach to the moveable diaphragm during operation. Hochareon et al. 16 showed that this configuration, in the similar 70 cc model, more closely resembles the motion of the blood sac in the clinical device.
The PF device is connected to a mock circulatory loop, developed by Rosenberg et al., 17 that mimics the physiological flows and pressures that the pump is exposed to in vivo. The compliance and resistance of the native system are lumped into a set of mechanical components that reproduce the pulsatile flow. The system is composed of a pump, two compliance chambers that simulate the elasticity of arteries and veins, a resistive element simulating the resistance to flow caused by arterioles and capillaries, and a fluid reservoir. Flow and pressure waveforms are monitored with ultrasonic flow meters (Transonic Systems, Inc., Ithaca, NY) and pressure transducers (Argon Medical Devices, Inc., Athens, TX) at the inlet and outlet of the device. The pusher plate is connected to a linear variable differential transformer (MACH 1 Series, Solartron Metrology, West Sussex, UK) to monitor its position throughout the cardiac cycle. A data acquisition system (WaveBook 512, IOtech, Inc., Norton, MA) with WaveView software is used to monitor all signals in real time through a PC. In these studies, a sinusoidal pusher plate motion is used with a systolic duration of 37% and a frequency of 86 beats/ min. To achieve the required stroke volume of 50 cc, the piston has a stroke length of 15 mm. The in vitro operating conditions for all pumps were kept constant to allow for direct flow comparisons.
A non-Newtonian blood analog composed of 0.03% xanthan gum, 16% glycerin, 33.97% water, and 50% sodium iodide by weight was used to model blood at a 40% hematocrit. 18 The sodium iodide was added to increase the refractive index of the solution to match the refractive index of the acrylic models. The viscosity and elasticity matched blood at 40% Hct and were verified through measurements made over shear rates of 1-1000 s Ϫ1 with a viscoelastic analyzer (Vilastic-3, Vilastic Scientific, Inc., Austin, TX). The blood analogs were seeded with 10 m diameter hollow glass spheres to provide light scattering for PIV.
For this investigation, dual pulsed neodymium-doped yttrium aluminium garnet (Nd:YAG) lasers, part of a Gemini PIV 15 system (New Wave Research, Inc., Fremont, CA), and coupled spherical and cylindrical lenses were used to produce a 200 m light sheet with approximately 120 mJ of energy per pulse and a pulse width of 5-10 ns. A one megapixel charge-coupled device (CCD) camera (TSI, Inc., Shoreview, MN) with a CCD chip size of 1,000 ϫ 1,016 pixels was aligned parallel to the light sheet to capture particle displacements. Both the laser and camera positions were controlled with traverses.
To coordinate image capture with laser firing, we used a LaserPulse Synchronizer (TSI, Inc.). The synchronizer was connected to a personal computer installed with Insight 6 software (TSI, Inc.) to control image acquisition and visualize particle displacements. Data collection at a given point in the cardiac cycle was controlled by a time-delayed trigger signal from the inflow waveform, visualized with an oscilloscope (Tektronics, Inc., Beaverton, OR). Two hundred image pairs were collected at different time points throughout the cardiac cycle for statistical averaging and to minimize beat-to-beat variability. Insight 3G (TSI, Inc.) was used to process the collected images. Each acquired image pair was subdivided into 32 ϫ 32 pixel interrogation regions, and particle displacements were calculated within all regions. A 50% overlap criteria was applied to the interrogation regions, such that the final spatial resolution of velocity vectors, as determined from individual particle pattern displacements, was every 16 pixels in the x and y directions. To improve accuracy, a deformation grid was chosen and a Hart correlation algorithm, cross-correlation engine, and a bilinear peak detection algorithm were used to decrease processing time.
Postprocessing of the images was done using Tecplot 10 (Tecplot, Inc., Bellevue, WA). For each time step, velocities within each interrogation region for all acquired image pairs were averaged. The resulting velocity maps are shown as a contour plot with different colors indicating velocity magnitude and with arrows giving flow direction.
PIV image pairs were taken in a cross-section of the body of the pumps, as well as in the inflow and outflow ports. The resolution was approximately 85 m/pixel for images in the main body of the pump and 25 m/pixel in the ports. For the main body, the light plane was adjusted with respect to the front wall of the model at distances of 3, 5, and 8 mm as shown in Figure 4A . Data were collected in 25-50 msec intervals after the onset of diastole throughout the 700 msec cycle. For the inflow and outflow ports, data were collected during points in the cardiac cycle of measureable flow; 25-400 msec after the onset of diastole for the inflow port and 350 -650 msec for the outflow port. Spatially, planar data was taken at the port centerline, Ϫ4 mm away from the model with respect to the centerline and 3 mm toward the model with respect to the centerline, as displayed in Figure 4B .
Results
There were few flow differences between the pumps in early (25-75 msec) and mid (100 -200 msec) diastole, which is expected due to the identical design of the pump inflow ports. Inlet port velocity maps for 150 msec into diastole, shown in Figure 5 , verify flow consistencies for all VADs at the port centerline. The flow field for all devices achieves a similar flow pattern through the major orifice of the valve, although a minor orifice flow separation is observed for V-4 only.
During late diastole (300 -400 msec), transition (400 -450), and through systole (450 -700 msec), the differences between the devices become more apparent as geometric changes to the outlet port have a greater influence on the flow. The 3, 5, and 8 mm planes of the pump chamber at 350 msec are shown in Figure 6 . At this point in the cycle, V-2 has the strongest rotational flow, particularly between the ports, whereas the configuration of outlet ports in V-3 and V-4 weakens this interport washing. Rotating the outlet port away from the inlet in V-3 minimized the amount of turning the fluid performed as the flow was directed toward the outlet of the device. This is further evident at the center plane of the outlet port 400 msec into the cycle, as shown in Figure 7 , where the bulk fluid enters the outlet port in V-3 before V-2 and V-4. At this point, a clockwise flow is observed in the lower half of the V-2 port, and no measureable flow is noted exiting the device. The V-4 outlet has a rotational flow, which is directed away from the major orifice of the valve and into the pump chamber. A jet can be observed exiting the minor orifice of the device. The outflow through V-3 continues to strengthen, with velocities of approximately 1.0 m/s observed near the center of the outlet port.
At 400 msec, flow maps of the three body planes, illustrated in Figure 8 , show that the rotational flow patterns are more developed with higher velocities between the ports. Although V-3 has the highest velocities between ports, V-2 has the most consistent interport washing for all three planes. At this point in the cardiac cycle, the rotational flow strengthens, and the higher inertial forces at this time prevent the outflow ports from having as large of an effect on the flow within the chambers. The rotational flow remains weak in the vicinity of the inflow ports, however, with minimal washing along the upper right wall of the pumps. V-2 has the strongest rotational flow of the three designs, and the washing remains consistent around the pump circumference in the three data planes. V-4 has the highest flow on the left wall of the pump chamber, which is likely due to a combination of the increased distance the fluid has to travel to the outlet port and the lack of flow disruption from the ports. Along the right lateral wall of the pump cham-ber, V-4 has the poorest wall washing with V-2 showing the best washing in this region.
Flow fields at 500 msec in the 5 mm plane for the three designs are shown in Figure 9 . The location of the outflow jet for each device corresponds to the location of the individual outlet ports. In V-3, the flow has to turn the least to exit the pump. The outflow in V-3 persists toward the bottom of the pump chamber and there continues to be adequate washing in that region. The flow has to make a significant turn for V-4, and there is a region of faster flow approaching the pump outlet to accommodate for the increased distance the fluid must travel The effects of moving the outlet port in V-4 toward the center of the pump chamber and rotated away from the inlet port are further realized in Figure 10 , where the center plane of the outlet port after 550 msec into the cardiac cycle is shown. The outflow is the slowest in V-3, although a strong minor orifice jet is present. The outflow is strongest in V-2 and V-4, with velocities Ͼ1 m/s spanning the width of the outflow port.
Discussion
These experiments were the first to focus on the position of the outflow port of design variations of the 50 cc PSU VAD.
Examination of the ports is an essential part of understanding the flow within the device. In contrast to earlier V-0 and V-1 designs, the ports were moved away from the pusher plate face to increase the amount of fluid between the blood sac and VAD wall, thus decreasing the stress on the diaphragm throughout the cardiac cycle. For the inlet port location with the designs described in this study, the inflow jet was more steeply angled to the pusher plate than in V-0 (as shown in Figure 1 ), thus there was an increase in three dimensionality of the inlet flow. As previous results have shown in V-0 with a less angled inlet port, 19 there is a tighter circulating flow. Rotational flow does develop for the three designs, but the pattern is not as uniform around the pump chamber, when compared with V-0. V-0 (shown in Figure 1 ) had less angled ports than V-2 to V-4, and although this enhanced the washing flow from the inlet jet, we were concerned that the pusher plate might catch the sac during operation. The design was changed, so that both ports were moved further from the pusher plate. The focus of the previous work [12] [13] [14] [15] 19 had been on the inlet jet and the resulting recirculating flow that develops. The current work focuses on the position of the outlet port, which has never been studied with these devices.
Although modifications to the outlet port locations did serve their intended purpose, they also introduced new problems. Rotating the outflow port away from the inflow and placing it lower in the model in V-3 allowed the outflow to exit the device sooner, preventing blood from remaining stagnant within the device and minimizing the time blood is in contact with surfaces of the pump. The outflow location did have a negative effect, however, as it hindered the complete development of the desired rotational flow pattern that promotes good wall washing throughout the pump. The distance between the inflow and outflow ports was large, and the flow was more inclined to enter the outflow port rather than turn along the outer wall of the pump and wash the region between the ports. The outflow preceded the outflow in the V-2 and V-4 devices by more than 50 msec. However, this outflow port location decreased the wall washing between the inflow and outflow ports and also seemed to promote the weakest rotational flow of the three pumps during diastole.
Placing the outlet port in the center of the pump in V-4 showed success in promoting better washing along the outlet wall of the pump chamber. This orientation, however, diminished washing between the ports at the top of the pump chamber. This lower level of washing is a cause for concern as these locations may be susceptible to thrombus formation. Although the differences between the devices were not large, the device that seems to have the most desirable characteristics is V-2. This design combines the best flow features of V-3 and V-4, having the most uniform rotational flow of the three designs. Wall washing to prevent thrombosis is consistent around the pump circumference for the three data planes. Not only does the inlet-side wall of the V-2 device show increased relative washing compared with the other devices, but greater flow exists between the ports to prevent areas of stagnation from forming. Therefore, initial fluid dynamic investigations suggest that V-2 would be the better choice for continued evaluation with both in vitro and in vivo experimentation. It should be noted that existing clinical VAD technology 20 -22 also uses parallel inlet and outlet ports though not all. 23
Conclusions
Although PF VADs have been shown to provide adequate temporary cardiac support in assisting the failing heart, thrombosis remains a complication limiting their long-term use. Studies have shown that thrombus formation in devices is a function of the fluid mechanics of VADs, particularly linked to areas of flow stasis, recirculation, and wall shear rates below 500 s Ϫ1 on a polyurethane blood sac. 24 PIV techniques allow these flow regimes to be visualized in an in vitro setting, enabling the study of design changes on the flow of VADs leading up to in vivo trials. Three models of a Penn State 50 cc device, scaled from a clinically successful 70 cc VAD and designated V-2, V-3, and V-4, were considered in this study to better understand the relationship between outlet port location and device flow. Model V-2 had parallel inlet and outlet ports intended to preserve a strong rotational flow within the pump body. V-3 was characterized by an outlet port rotated tangent to the device and moved lower in the pump to decrease the amount of time blood remained in contact with the foreign blood sac surface. V-4 included an outlet port shifted nearer the inlet port to increase the amount of wall washing within the device in hopes of limiting clot deposition. PIV results at three planar body, and three planar port locations revealed that shifting the outlet port led to the intended result but caused too little wall washing in V-3 and little flow between ports in V-4. Flow was more appropriately sustained in these areas within V-2, as its intermediate port location combined favorable flow aspects of the other devices, and we conclude that V-2 is the model of choice. Additional work in flow field modification by changing the relative position of the inlet and outlet ports is probably not warranted.
